New York Life Investment Management’s Fabrinet FN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-3,628
Closed -$1.32M 804
2025
Q3
$1.32M Sell
3,628
-163
-4% -$53.7K 0.01% 610
2025
Q2
$1.12M Buy
+3,791
New +$845K 0.01% 627
2025
Q1
Sell
-3,822
Closed -$840K 830
2024
Q4
$840K Sell
3,822
-350
-8% -$84.4K 0.01% 698
2024
Q3
$986K Sell
4,172
-239
-5% -$55.3K 0.01% 702
2024
Q2
$1.08M Buy
4,411
+400
+10% +$84.8K 0.01% 662
2024
Q1
$758K Sell
4,011
-104
-3% -$20.9K 0.01% 738
2023
Q4
$783K Buy
+4,115
New +$705K 0.01% 721

Other funds holding FN

New York Life Investment Management's FN Position: Q4 2025 in Review

New York Life Investment Management sold out of Fabrinet (FN) in Q4 2025, closing a stake of 3,628 shares — an estimated $1.32M sold.

New York Life Investment Management first reported a position in FN in Q4 2023 and held it in 7 quarters. The position peaked at $1.32M in Q3 2025. 582 funds tracked by Wall St. Rank hold FN as of Q4 2025.

  • New York Life Investment Management reported no remaining Fabrinet position as of Q4 2025 after selling out during the quarter.
  • New York Life Investment Management sold 3,628 Fabrinet shares in Q4 2025, an estimated $1.32M.
  • New York Life Investment Management first reported a position in Fabrinet in Q4 2023 and held it in 7 quarters.
  • New York Life Investment Management's Fabrinet position peaked at $1.32M in Q3 2025.
  • 582 funds tracked by Wall St. Rank held Fabrinet as of Q4 2025.

Based on New York Life Investment Management's 13F filing for Q4 2025, filed 5 Feb 2026.